BostonGene

Lymphly is a transparent, evidence-based classifier developed to enhance biological resolution and improve patient stratification for clinical trials and treatment selection.

[UNDER DEVELOPMENT] Pipeline for mapping and annotating T- and B-cell receptor gene rearrangement sequences

Extended somatic reference standards of model cancer cell lines

Mollecular Functional Portraits

Functions for classifying DLBCL into LME types